Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Alternative Payment Models
- Biopharmaceutical Innovation
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- High-Deductible Health Plans
- IRA Implementation
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Utilization Management & Step Therapy
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Audience
Audience
Display Only
Showing 253 Results
NPC Comments on CMS Proposed Rule on Medicaid Best Price, Value-based Purchasing
NPC outlines barriers and potential solutions to the broader use of value-based purchasing agreements.
National Pharmaceutical Council and Duke-Margolis Center for Health Policy Announce New Health Policy Fellow
Dr. Salama Freed has been named NPC/Duke-Margolis Health Policy Fellow for 2020-22.
Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair
NPC announced that Blasine Penkowski, MBA, Chief Strategic Customer Officer of Johnson & Johnson Health Care Systems Inc., has been elected Chair of NPC’s Board of Directors for 2019-2020.